DGAP-PVR: Probiodrug AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

| Source: EQS Group AG EQS Group AG 

Probiodrug AG 

07.11.2014 19:50

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Probiodrug AG

Halle (Saale), Germany

Handelsregister: Amtsgericht Stendal, HRB 213719
(Commercial Register: Local Court of Stendal, HRB 213719)

ISIN: DE0007921835

Publication of notifications of voting rights pursuant to sec. 21 para. 1a
WpHG (Wertpapierhandelsgesetz - German Securities Trading Act)

1.

Coöperatief LSP IV U.A., Johannes Vermeerplein 9, 1071 DV Amsterdam,
Netherlands, informed our company pursuant to sec. 21 para. 1a WpHG (German
Securities Trading Act) on October 31, 2014, that its voting rights
proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany,
ISIN DE0007921835, amounted to 8.45% on October 27, 2014 (corresponding to
442.806 voting rights).

2.

LSP IV Management B.V., Johannes Vermeerplein 9, 1071 DV Amsterdam,
Netherlands, informed our company pursuant to sec. 21 para. 1a WpHG (German
Securities Trading Act) on November 3, 2014, that its voting rights
proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany,
ISIN DE0007921835, amounted to 8.45% on October 27, 2014 (corresponding to
442.806 voting rights). 8.45% of the voting rights (corresponding to
442.806 voting rights) are to be attributed to LSP IV Management B.V.
pursuant to sec. 22 para. 2 sentence 1 no. 6 WpHG. The voting rights that
are to be attributed to LSP IV Management B.V. are held via the following
company whose holdings of voting rights amount to 3% or more in Probiodrug
AG: Coöperatief LSP IV U.A.

3.

LSP Management Group B.V., Johannes Vermeerplein 9, 1071 DV Amsterdam,
Netherlands, informed our company pursuant to sec. 21 para. 1a WpHG (German
Securities Trading Act) on November 4, 2014, that its voting rights
proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany,
ISIN DE0007921835, amounted to 8.45% on October 27, 2014 (corresponding to
442.806 voting rights). 8.45% of the voting rights (corresponding to
442.806 voting rights) are to be attributed to LSP Management Group B.V.
pursuant to sec. 22 para. 2 sentence 1 no. 6 and sentence 2 WpHG. The
voting rights that are to be attributed to LSP Management Group B.V. are
held via the following company whose holdings of voting rights amount to 3%
or more in Probiodrug AG: Coöperatief LSP IV U.A.

4.

Biotech Growth N.V., Snipweg 26, Willemstad, Curacao, the Netherlands
Antilles (Dutch Caribbean), informed our company pursuant to sec. 21 para.
1a WpHG (German Securities Trading Act) on October 31, 2014, that its
voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle
(Saale), Germany, ISIN DE0007921835, amounted to 15.06% on October 27, 2014
(corresponding to 789,439 voting rights).

5.

BB Biotech AG, Vordergasse 3, 8200 Schaffhausen, Switzerland, informed our
company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act)
on November 3, 2014, that its voting rights proportion in Probiodrug AG,
Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted
to 15.06% on October 27, 2014 (corresponding to 789,439 voting rights).
15.06% of the voting rights (corresponding to 789,439 voting rights) are to
be attributed to BB Biotech AG pursuant to sec. 22 para. 2 sentence 1 no. 1
WpHG. The voting rights that are to be attributed to BB Biotech AG are held
via the following company whose holdings of voting rights amount to 3% or
more in Probiodrug AG: Biotech Growth N.V.

6.

HBM Healthcare Investments (Cayman) Ltd., Governor's Square, Suite
#4-212-2, 23 Lime Tree Bay Avenue, George Town, Grand Cayman, Cayman
Islands, informed our company pursuant to sec. 21 para. 1a WpHG (German
Securities Trading Act) on October 31, 2014, that its voting rights
proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany,
ISIN DE0007921835, amounted to 9.44% on October 27, 2014 (corresponding to
494,825 voting rights).

7.

HBM Healthcare Investments AG, Bundesplatz 1, 6301 Zug, Switzerland,
informed our company pursuant to sec. 21 para. 1a WpHG (German Securities
Trading Act) on October 31, 2014, that its voting rights proportion in
Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN
DE0007921835, amounted to 9.44% on October 27, 2014 (corresponding to
494,825 voting rights). 9.44% of the voting rights (corresponding to
494,825 voting rights) are to be attributed to HBM Healthcare Investments
AG pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. The voting rights
that are to be attributed to HBM Healthcare Investments AG are held via the
following company whose holdings of voting rights amount to 3% or more in
Probiodrug AG: HBM Healthcare Investments (Cayman) Ltd.

8.

Edmond de Rothschild Investment Partners, 47 rue du Faubourg Saint Honoré,
75008 Paris, France, informed our company pursuant to sec. 21 para. 1a WpHG
(German Securities Trading Act) on November 6, 2014, that its voting rights
proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany,
ISIN DE0007921835, amounted to 15.67% on October 27, 2014 (corresponding to
821,409 voting rights). 15.67% of the voting rights (corresponding to
821,409 voting rights) are to be attributed to Edmond de Rothschild
Investment Partners pursuant to sec. 22 para. 2 sentence 1 no. 6 WpHG.

9.

IBG Risikokapitalfonds I GmbH & Co. KG, Kantstraße 5, 39104 Magdeburg,
Germany, informed our company pursuant to sec. 21 para. 1a WpHG (German
Securities Trading Act) on October 31, 2014, that its voting rights
proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany,
ISIN DE0007921835, amounted to 9.51% on October 27, 2014 (corresponding to
498,549 voting rights).

10.

IBG Risikokapitalfonds II GmbH & Co. KG, Kantstraße 5, 39104 Magdeburg,
Germany, informed our company pursuant to sec. 21 para. 1a WpHG (German
Securities Trading Act) on October 31, 2014, that its voting rights
proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany,
ISIN DE0007921835, amounted to 7.71% on October 27, 2014 (corresponding to
404,261 voting rights).

11.

IBG Beteiligungsverwaltung Komplementär GmbH, Kantstraße 5, 39104
Magdeburg, Germany, informed our company pursuant to sec. 21 para. 1a WpHG
(German Securities Trading Act) on October 31, 2014, that its voting rights
proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany,
ISIN DE0007921835, amounted to 17.48% on October 27, 2014 (corresponding to
916,435 voting rights). 17.48% of the voting rights (corresponding to
916,435 voting rights) are to be attributed to IBG Beteiligungsverwaltung
Komplementär GmbH pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. The
voting rights that are to be attributed to IBG Beteiligungsverwaltung
Komplementär GmbH are held via the following companies whose holdings of
voting rights amount to 3% or more in Probiodrug AG: IBG Risikokapitalfonds
I GmbH & Co. KG, IBG Risikokapitalfonds II GmbH & Co. KG.

12.

IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, Kantstraße 5, 39104
Magdeburg, Germany, informed our company pursuant to sec. 21 para. 1a WpHG
(German Securities Trading Act) on October 31, 2014, that its voting rights
proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany,
ISIN DE0007921835, amounted to 18.12% on October 27, 2014 (corresponding to
949,607 voting rights). 17.48% of the voting rights (corresponding to
916,435 voting rights) are to be attributed to IBG Beteiligungsgesellschaft
Sachsen-Anhalt mbH pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. The
voting rights that are to be attributed to IBG Beteiligungsgesellschaft
Sachsen-Anhalt mbH are held via the following companies whose holdings of
voting rights amount to 3% or more in Probiodrug AG: IBG
Beteiligungsverwaltung Komplementär GmbH, IBG Risikokapitalfonds I GmbH &
Co. KG, IBG Risikokapitalfonds II GmbH & Co. KG.

13.

Sachsen-Anhalt, Land - Ministerium der Finanzen des Landes Sachsen-Anhalt,
Olvenstedter Straße 1-2, 39108 Magdeburg, Germany, informed our company
pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on
October 31, 2014, that its voting rights proportion in Probiodrug AG,
Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted
to 18.12% on October 27, 2014 (corresponding to 949,607 voting rights).
18.12% of the voting rights (corresponding to 949,607 voting rights) are to
be attributed to Sachsen-Anhalt, Land - Ministerium der Finanzen des Landes
Sachsen-Anhalt, pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. The
voting rights that are to be attributed to Sachsen-Anhalt, Land -
Ministerium der Finanzen des Landes Sachsen-Anhalt, are held via the
following companies whose holdings of voting rights amount to 3% or more in
Probiodrug AG: IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, IBG
Beteiligungsverwaltung Komplementär GmbH, IBG Risikokapitalfonds I GmbH &
Co. KG, IBG Risikokapitalfonds II GmbH & Co. KG,

14.

Biogen Idec MA Inc., 14 Cambridge Center, Cambridge, MA 02142, USA,
informed our company pursuant to sec. 21 para. 1a WpHG (German Securities
Trading Act) on November 5, 2014, that its voting rights proportion in
Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN
DE0007921835, amounted to 4.04% on October 27, 2014 (corresponding to
211,651 voting rights).

15.

Biogen Idec Inc., 225 Binney Street, Cambridge, MA 02142, USA, informed our
company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act)
on October 30, 2014, that its voting rights proportion in Probiodrug AG,
Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted
to 4.04% on October 27, 2014 (corresponding to 211,651 voting rights).
4.04% of the voting rights (corresponding to 211,651 voting rights) are to
be attributed to Biogen Idec Inc. pursuant to sec. 22 para. 2 sentence 1
no. 1 WpHG. The voting rights that are to be attributed to Biogen Idec Inc.
are held via the following company whose holdings of voting rights amount
to 3% or more in Probiodrug AG: Biogen Idec MA Inc.

16.

TVM V Life Science Ventures GmbH & Co. KG, Ottostraße 4, 80797 Munich,
Germany, informed our company pursuant to sec. 21 para. 1a WpHG (German
Securities Trading Act) on October 31, 2014, that its voting rights
proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany,
ISIN DE0007921835, amounted to 9.53% on October 27, 2014 (corresponding to
499,368 voting rights).

17.

TVM V Life Science Management GmbH & Co. KG, Ottostraße 4, 80797 Munich,
Germany, informed our company pursuant to sec. 21 para. 1a WpHG (German
Securities Trading Act) on October 31, 2014, that its voting rights
proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany,
ISIN DE0007921835, amounted to 9.53% on October 27, 2014 (corresponding to
499,368 voting rights). 9.53% of the voting rights (corresponding to
499,368 voting rights) are to be attributed to TVM V Life Science
Management GmbH & Co. KG pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG.
The voting rights that are to be attributed to TVM V Life Science
Management GmbH & Co. KG are held via the following company whose holdings
of voting rights amount to 3% or more in Probiodrug AG: TVM V Life Science
Ventures GmbH & Co. KG.

18.

Wellington Hedge Management, LLC, Corporate Service Company, 84 State
Street, Boston, MA 02109, USA, informed our company pursuant to sec. 21
para. 1a WpHG (German Securities Trading Act) on November 6, 2014, that its
voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle
(Saale), Germany, ISIN DE0007921835, amounted to 3.05% on October 27, 2014
(corresponding to 160,049 voting rights). 3.05% of the voting rights
(corresponding to 160,049 voting rights) are to be attributed to Wellington
Hedge Management, LLC pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG.

19.

Wellington Management Company, LLP, 280 Congress Street, Boston,
Massachusetts 02210, USA, informed our company pursuant to sec. 21 para. 1a
WpHG (German Securities Trading Act) on November 6, 2014, that its voting
rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale),
Germany, ISIN DE0007921835, amounted to 4.06% on October 27, 2014
(corresponding to 212,771 voting rights). 4.06% of the voting rights
(corresponding to 212,771 voting rights) are to be attributed to Wellington
Management Company, LLP, pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG,
and also concurrently pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG.
The voting rights that are to be attributed to Wellington Management
Company, LLP are held via the following company whose holdings of voting
rights amount to 3% or more in Probiodrug AG: Wellington Hedge Management,
LLC.

Halle (Saale), in November 2014

The Management 



07.11.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Probiodrug AG
              Weinbergweg 22
              06120 Halle/Saale
              Germany
Internet:     www.probiodrug.de
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------